Advertisement
Screener

Theriva Biologics, Inc. (TOVX) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities

1.8 / 5 stars · 21/57 Roast Me

Theriva Biologics, Inc. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities

Theriva Biologics, Inc. (TOVX) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities of $277.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-25.

Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation

us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities · last filed 2024-03-25

  • Theriva Biologics, Inc. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2022-06-30 was $277.00K.
  • Theriva Biologics, Inc. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for fiscal 2022 was $277.00K.
Period endBusiness Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 3 monthBusiness Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 12 month
2022-12-31$277.00K
10-K · filed 2024-03-25
2022-06-30$277.00K
10-Q · filed 2022-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Medicus Pharma Ltd. (MDCX)$0.010B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92